Emerging ELISA Dynex Technologies recently launched the DS2 Elite automated ELISA system in early 2026, signaling a push toward advanced workflow automation and connected, modern user experiences. This presents an opportunity to position complementary automation, data integration, and service offerings to labs upgrading their diagnostic capabilities.

Lab Diagnostics Growth Historical product launches such as Agility Integra and partnerships indicate an ongoing expansion in laboratory diagnostic equipment and multiplex biomarker testing. Leverage this trajectory to propose expanded product lines, service contracts, and cross-sell of reagents or configurables for lab workflows.

Strategic Partnerships Past collaborations with ALPCO and ZEUS Scientific demonstrate a pattern of ecosystem partnerships. Target outreach to distributors and life sciences OEMs for joint go-to-market efforts, channel partnerships, and co-branded solutions to broaden market reach.

Virginia Manufacturing Momentum Recognition as a standout Virginia-made innovation suggests regional credibility and potential for localized sales initiatives, joint marketing, and government or state-funded lab modernization programs to accelerate adoption in nearby facilities.

Financial Scale Gap With revenue under $1M and a lean organization, there is an opportunity to position scalable, cost-efficient solutions, bundled service plans, and favorable terms for small-to-mid-sized labs, while highlighting case studies and ROI to accelerate procurement decisions.